Euroapi SAS
PAR:EAPI
Euroapi SAS
Net Change in Cash
Euroapi SAS
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
E
|
Euroapi SAS
PAR:EAPI
|
Net Change in Cash
€40.7m
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Sanofi SA
PAR:SAN
|
Net Change in Cash
-€1.2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
![]() |
Ipsen SA
PAR:IPN
|
Net Change in Cash
€158.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
41%
|
CAGR 10-Years
11%
|
|
![]() |
Vetoquinol SA
PAR:VETO
|
Net Change in Cash
€57.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
25%
|
|
![]() |
Virbac SA
PAR:VIRP
|
Net Change in Cash
-€50.3m
|
CAGR 3-Years
-89%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Medincell SA
PAR:MEDCL
|
Net Change in Cash
€4.9m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Net Change in Cash?
Net Change in Cash
40.7m
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Net Change in Cash amounts to 40.7m EUR.
What is Euroapi SAS's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
58%
The average annual Net Change in Cash growth rates for Euroapi SAS have been 58% over the past three years .